Literature DB >> 15157216

Cut-to-the-light technique and potassium titanyl phosphate laser ureterotomy for complete ureteral obstruction.

Kazumasa Goda1, Gaku Kawabata, Tomihiko Yasufuku, Isao Hara, Masato Fujisawa, Sadao Kamidono, Hiroshi Okada.   

Abstract

We describe a case of complete ureteral obstruction managed by endoscopic recanalization using a 'cut-to-the-light' technique followed by potassium titanyl phosphate (KTP) laser ureterotomy. A 53-year-old man developed a ureteral obstruction following the transurethral resection of a bladder tumor (TUR-Bt) at the left ureteral orifice. The length of the obstructed segment was estimated at 1 cm based on combined antegrade and retrograde contrast studies. Histopathological analysis indicated that the obstruction was caused by fibrosis. The 'cut-to-the-light' technique was used for recanalization, and KTP laser ureterotomy was performed to obtain an adequate ureteral lumen. A 14 F/7 F endoureterotomy stent was removed 6 weeks after the operation. No significant complications and no signs of stenosis were observed 24 months after endoscopic repair. Endoscopic recanalization is a safe, effective technique for the management of a completely obliterated ureteral segment, especially in combination with subsequent KTP laser ureterotomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157216     DOI: 10.1111/j.1442-2042.2004.00817.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Simultaneous antegrade and retrograde endoscopic treatment of non-malignant ureterointestinal anastomotic strictures following urinary diversion.

Authors:  Weiguo Hu; Boxing Su; Bo Xiao; Xin Zhang; Song Chen; Yuzhe Tang; Yubao Liu; Meng Fu; Jianxing Li
Journal:  BMC Urol       Date:  2017-08-08       Impact factor: 2.264

2.  Minimally invasive surgical treatment on delayed uretero-vaginal fistula.

Authors:  Xinying Li; Ping Wang; Yili Liu; Chunlai Liu
Journal:  BMC Urol       Date:  2018-10-29       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.